A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain
Status:
Not yet recruiting
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
Multi-center, randomized, double-blind, parallel-group study to confirm superiority of
KLH-2109 to placebo in uterine fibroids patient with menorrhagia and pain